Marc Blaustein - Sep 8, 2021 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
Sep 8, 2021
Transactions value $
$0
Form type
3
Date filed
9/10/2021, 04:23 PM
Next filing
Feb 28, 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney